Nipro To Snap Up Home Diagnostics For $215M

Law360, New York (February 3, 2010, 12:48 PM EST) -- Nipro Corp. revealed Wednesday that it was set to fork out $215 million to acquire diabetes testing supply maker Home Diagnostics Inc., a move that will allow the Japanese medical device manufacturer to launch its pump products in the U.S. market.

The two companies said they had signed a definitive merger agreement under which Nipro will acquire all outstanding shares of Home Diagnostics’ common stock for a cash purchase price of $11.50 per share.

The offer price represents an approximately 90 percent premium to the closing...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.